Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213726 · ClinicalTrials.gov registry record · NA
Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System
A NA study of Blood Flow Restriction (BFR) Training Effects, sponsored by Andrews Research & Education Foundation.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07213726 is a NA study of Blood Flow Restriction (BFR) Training Effects that is active but no longer recruiting, run by Andrews Research & Education Foundation. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07213726, a NA study of Blood Flow Restriction (BFR) Training Effects, is active but no longer recruiting, sponsored by Andrews Research & Education Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational study is to examine how slowing down blood flow to the legs- a practice called blood flow restriction (BFR)- during exercise by applying compression to the legs affects the way stem cells are released into the blood stream. This will be determined by drawing 6 cubic centimeters (ccs) of blood immediately post-exercise after the Delfi Personalized Tourniquet System (PTS) has been removed. 6 ccs of blood will also be taken prior to exercise and at the 20-, 40-, and 60-minute marks after exercise. The main question of this study is: • Will the levels of stem cells extracted before and after exercise be the same if blood flow is restricted during exercise? In this study, participants will undergo the following: * 6 ccs of blood extracted from the forearm prior to exercise to establish a baseline * 3 exercises- seated leg extension, semi-reclined leg press, and seated hamstring curl- consisting of 4 sets of 30-15-15-15 repetitions per exercise; resistance will be set to 30% of one-rep maximum (1-RM) * Additional 6 cc blood draws will be performed immediately post-exercise and after 20, 40, and 60 minutes have elapsed
Conditions Studied
Interventions
- DEVICE Delfi Personalized Tourniquet System
Study Locations (1)
Florida
- Andrews Institute for Orthopaedics & Sports Medicine - Gulf Breeze
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-08-16 |
| Est. Completion | 2026-11-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07213726
The ClinicalTrials.gov registry entry for NCT07213726 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andrews Research & Education Foundation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Flow Restriction (BFR) Training Effects appearing as the primary indexed condition, and to 1 intervention - of which Delfi Personalized Tourniquet System is the first listed.
NCT07213726 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07213726 about?
NCT07213726 is a clinical study titled "Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System". The purpose of this observational study is to examine how slowing down blood flow to the legs- a practice called blood flow restriction (BFR)- during exercise by applying compression to the legs affects the way stem cells are released into the blood stream. This will be determined by drawing 6 cubic...
What is the current status of trial NCT07213726?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2022-08-16. Estimated completion is 2026-11-20.
What conditions does trial NCT07213726 study?
This clinical trial studies the following conditions: Blood Flow Restriction (BFR) Training Effects.
What interventions are being tested in trial NCT07213726?
The interventions under investigation include: Delfi Personalized Tourniquet System (DEVICE).
Who is sponsoring clinical trial NCT07213726?
This trial is sponsored by Andrews Research & Education Foundation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07213726 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.